Security key
21217B100
Contineum Therapeutics, Inc. - Class A Stock (CTNM)
CUSIP: 21217B100
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Class A Stock
- Total 13F shares
- 13,016,510
- Total 13F value
- $229,220,181
- Share change
- +13,012,275
- SEC-reported price per share
- $17.61
- Number of holders
- 49
- Value change
- +$229,145,565
- Number of buys
- 47
- Shares outstanding
- 32,531,635
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
49
Top holders
10
CTNM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Contineum Therapeutics, Inc. SEC filings
Contineum Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 21217B100
Recent filing periods:
Ownership snapshot
Top reported holders of CTNM - Contineum Therapeutics, Inc. - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
JOHNSON & JOHNSON
Disclosed value leader
JOHNSON & JOHNSON
Comparable rows
0/2
Latest evidence
09 Apr 2024
3/4/5
Highest disclosed value: $33,744,900
2 rows are not safely comparable across share classes.
Quick read
JOHNSON & JOHNSON has the largest disclosed position value at $33.74M.
0 of 2 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens JOHNSON & JOHNSON's linked filing trail.
Disclosed position value
Top 2
JOHNSON & JOHNSON
$33.74M
Versant Venture Capital VI, L.P.
$8.93M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-2 of 2 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| JOHNSON & JOHNSON |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$33,744,900
1,979,173 shares
|
— | 09 Apr 2024 |
| Versant Venture Capital VI, L.P. |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$8,931,592
4,842,544 shares
mixed-class rows
|
— | 09 Apr 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
49
Shares
13,016,510
Rows available
49
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
0
Q2 2024 holders
49
Holder diff
49
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend